$Sarepta Therapeutics (SRPT.US)$ SO THIS IS WHY ? Last quarter they raised the 2021 guidance to 605-615M and the slide in the presentation shows 612M unaudited annual revenue. $2.1B in cash. There is absolutely no reason the stock to sell off 12%, it is exactly what they guided , this is absolutely the best buying opportunity in the biotech sector period. Sarepta should be trading at $15B not pathetic 6.5B !
2021 Guidance Raised
Sarepta raised its guidance for revenue...
2021 Guidance Raised
Sarepta raised its guidance for revenue...
![Sarepta is way UNDERVALUED](https://ussnsimg.moomoo.com/moo-1641850277-70671410-iPhone-1-org.jpg/thumb)
$Lumentum (LITE.US)$ anyone notice the volume yesterday?
$Onconova Therapeutics (ONTX.US)$ email to CEO to RESIGN SFRUCHTMAN@ONCONOVA.US ir@onconova.us this pattern of investors dilution has to STOP 🛑
$Onconova Therapeutics (ONTX.US)$ email CEO SFRUCHTMAN@ONCONOVA.US to resign. we need new management.
1
$Onconova Therapeutics (ONTX.US)$ this company market cap is way too low it is run by James Marino who brought celtex from 34 cents to $50 it will do the same with Onconova. trillium sold for 2 billion ! $Biocept (BIOC.US)$ is another top takeover candidate , micro cap at this point
1
$Biocept (BIOC.US)$ the market cap of 50M is way too undervalued. $Exact Sciences (EXAS.US)$ will buy this company
4